Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
Antibody Level Predicts the Clinical Course of Breakthrough Infection of COVID-19 Caused by Delta and Omicron Variants: A Prospective Cross-Sectional Study.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Jul2022, Vol. 9 Issue 7, p1-8. 8p.
Abstract: Background Omicron variant viruses spread rapidly, even in individuals with high vaccination rates. This study aimed to determine the utility of the antibody against spike protein level as a predictor of the disease course of coronavirus disease 2019 (...
Clinical Features and Duration of Viral Shedding in Individuals With SARS-CoV-2 Omicron Variant Infection.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Jul2022, Vol. 9 Issue 7, p1-3. 3p.
Abstract: We analyzed the duration of infectivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant by viral culture of respiratory samples collected daily from isolated patients with SARS-CoV-2 infection. The culture positivity...
Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Aug2022, Vol. 9 Issue 8, p1-2. 2p.
Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Oct2022, Vol. 9 Issue 10, p1-5. 5p.
Abstract: Background COVID-19 medicines delivery units (CMDU) were established in late December 2021 to deliver early antiviral therapy to patients classified as at risk with the aim of preventing hospitalization. Methods We performed a service evaluation at 4 C...
Which Curve Are We Flattening? The Disproportionate Impact of COVID-19 Among Economically Marginalized Communities in Ontario, Canada, Was Unchanged From Wild-Type to Omicron.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Jan2023, Vol. 10 Issue 1, p1-4. 4p.
Abstract: Person-level surveillance (N = 14 million) and neighborhood-level income data were used to explore magnitude of inequalities in COVID-19 hospitalizations and deaths over 5 waves in Ontario, Canada. Despite attempts at equity-informed policies alongside...
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Oct2022, Vol. 9 Issue 10, p1-8. 8p.
Abstract: Background Monoclonal antibody (mAb) treatment is associated with decreased risk of hospitalization and death in high-risk outpatients with mild to moderate coronavirus disease 2019 (COVID-19) caused by early severe acute respiratory syndrome coronavir...
Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI).
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases; Jan2023, Vol. 10 Issue 1, p1-10, 10p
Abstract: Copyright of Open Forum Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, user...
Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Dec2022, Vol. 9 Issue 12, p1-7. 7p.
Abstract: Background Vaccine effectiveness against the severe acute respiratory syndrome coronavirus 2 Omicron BA.2 sublineage in Japan is unknown. We assessed the effectiveness of a third dose of COVID-19 mRNA vaccine compared with that of 2 doses. Methods We p...
Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Dec2022, Vol. 9 Issue 12, p1-4. 4p.
Abstract: In high-risk individuals in Johannesburg, during the Delta coronavirus disease 2019 wave, 22% (125/561) were positive, with 33% symptomatic (2 hospitalizations; 1 death). During Omicron, 56% (232/411) were infected, with 24% symptomatic (no hospitaliza...
Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch.
Publication Type: Academic Journal
Source(s): Open Forum Infectious Diseases. Oct2022, Vol. 9 Issue 10, p1-7. 7p.
Abstract: Background Antispike monoclonal antibodies are recommended for early treatment of high-risk persons with mild to moderate coronavirus disease 2019 (COVID-19). However, clinical outcomes of their use during the severe acute respiratory syndrome coronavi...